122 related articles for article (PubMed ID: 38751042)
1. Binding Mechanism between Platelet Glycoprotein and Cyclic Peptide Elucidated by McMD-Based Dynamic Docking.
Bekker GJ; Oshima K; Araki M; Okuno Y; Kamiya N
J Chem Inf Model; 2024 May; 64(10):4158-4167. PubMed ID: 38751042
[TBL] [Abstract][Full Text] [Related]
2. Specific electrostatic interactions between charged amino acid residues regulate binding of von Willebrand factor to blood platelets.
Interlandi G; Yakovenko O; Tu AY; Harris J; Le J; Chen J; López JA; Thomas WE
J Biol Chem; 2017 Nov; 292(45):18608-18617. PubMed ID: 28924049
[TBL] [Abstract][Full Text] [Related]
3. Refrigeration-Induced Binding of von Willebrand Factor Facilitates Fast Clearance of Refrigerated Platelets.
Chen W; Druzak SA; Wang Y; Josephson CD; Hoffmeister KM; Ware J; Li R
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2271-2279. PubMed ID: 29097365
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein Ibalpha inhibitor complex structure reveals a combined steric and allosteric mechanism of von Willebrand factor antagonism.
McEwan PA; Andrews RK; Emsley J
Blood; 2009 Nov; 114(23):4883-5. PubMed ID: 19726719
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Cyclic Glycoprotein Ibα-Derived Peptides Interfering with von Willebrand Factor-Binding, Affecting Platelet Aggregation under Shear.
Hrdinova J; Fernández DI; Ercig B; Tullemans BME; Suylen DPL; Agten SM; Jurk K; Hackeng TM; Vanhoorelbeke K; Voorberg J; Reutelingsperger CPM; Wichapong K; Heemskerk JWM; Nicolaes GAF
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216161
[TBL] [Abstract][Full Text] [Related]
7. The membrane-proximal intermolecular disulfide bonds in glycoprotein Ib influence receptor binding to von Willebrand factor.
Mo X; Luo SZ; Munday AD; Sun W; Berndt MC; López JA; Dong JF; Li R
J Thromb Haemost; 2008 Oct; 6(10):1789-95. PubMed ID: 18647229
[TBL] [Abstract][Full Text] [Related]
8. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
[TBL] [Abstract][Full Text] [Related]
9. Humanized GPIbα-von Willebrand factor interaction in the mouse.
Kanaji S; Orje JN; Kanaji T; Kamikubo Y; Morodomi Y; Chen Y; Zarpellon A; Eberhardt J; Forli S; Fahs SA; Sood R; Haberichter SL; Montgomery RR; Ruggeri ZM
Blood Adv; 2018 Oct; 2(19):2522-2532. PubMed ID: 30287479
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations.
Dumas JJ; Kumar R; McDonagh T; Sullivan F; Stahl ML; Somers WS; Mosyak L
J Biol Chem; 2004 May; 279(22):23327-34. PubMed ID: 15039442
[TBL] [Abstract][Full Text] [Related]
11. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha.
Cauwenberghs N; Vanhoorelbeke K; Vauterin S; Westra DF; Romo G; Huizinga EG; Lopez JA; Berndt MC; Harsfalvi J; Deckmyn H
Blood; 2001 Aug; 98(3):652-60. PubMed ID: 11468163
[TBL] [Abstract][Full Text] [Related]
12. Prediction of binding characteristics between von Willebrand factor and platelet glycoprotein Ibα with various mutations by molecular dynamic simulation.
Goto S; Oka H; Ayabe K; Yabushita H; Nakayama M; Hasebe T; Yokota H; Takagi S; Sano M; Tomita A; Goto S
Thromb Res; 2019 Dec; 184():129-135. PubMed ID: 31739151
[TBL] [Abstract][Full Text] [Related]
13. Identification of a small molecule that modulates platelet glycoprotein Ib-von Willebrand factor interaction.
Broos K; Trekels M; Jose RA; Demeulemeester J; Vandenbulcke A; Vandeputte N; Venken T; Egle B; De Borggraeve WM; Deckmyn H; De Maeyer M
J Biol Chem; 2012 Mar; 287(12):9461-72. PubMed ID: 22232560
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
Ju L; Dong JF; Cruz MA; Zhu C
J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
[TBL] [Abstract][Full Text] [Related]
15. Platelet-type von Willebrand disease: Local disorder of the platelet GPIbα β-switch drives high-affinity binding to von Willebrand factor.
Tischer A; Machha VR; Moon-Tasson L; Auton M
J Thromb Haemost; 2019 Dec; 17(12):2022-2034. PubMed ID: 31448872
[TBL] [Abstract][Full Text] [Related]
16. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.
Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS
Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340
[TBL] [Abstract][Full Text] [Related]
17. Oxidation shuts down an auto-inhibitory mechanism of von Willebrand factor.
Tsai R; Interlandi G
Proteins; 2021 Jun; 89(6):731-741. PubMed ID: 33550613
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Molecular Interaction between Platelet Glycoprotein Ibα and von Willebrand Factor using Molecular Dynamics Simulations.
Shiozaki S; Takagi S; Goto S
J Atheroscler Thromb; 2016; 23(4):455-64. PubMed ID: 26581184
[TBL] [Abstract][Full Text] [Related]
19. A mechanism for localized dynamics-driven affinity regulation of the binding of von Willebrand factor to platelet glycoprotein Ibα.
Liu G; Fang Y; Wu J
J Biol Chem; 2013 Sep; 288(37):26658-67. PubMed ID: 23902764
[TBL] [Abstract][Full Text] [Related]
20. Filamin A binding to the cytoplasmic tail of glycoprotein Ibalpha regulates von Willebrand factor-induced platelet activation.
Feng S; Reséndiz JC; Lu X; Kroll MH
Blood; 2003 Sep; 102(6):2122-9. PubMed ID: 12791664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
